The leading source for credible citizen reporting

Report Your News
Take the tour...

Phytopharm soars 340% on drug trial

Source: The Independent
London : United Kingdom | about 1 month ago  
Views: 9
The biotechnology minnow Phytopharm received a huge share price boost yesterday after announcing that early trials of its potential Parkinson's disease treatment had produced impressive results. Phytopharm's shares closed up 339.6 per cent at 26.95p after the group said that during an 18 week...
  • Print
  • Share:
  • Share
  • Digg
  • Reddit
  • Facebook
  • Stumbleupon

Related Allvoices Contributions

News Stories
 
  • News Source: The Independent | about 1 month ago
    The biotechnology minnow Phytopharm received a huge share price boost yesterday after announcing that early trials of its potential Parkinson's disease treatment had produced impressive results. Phytopharm's shares closed up 339.6 per cent at 26.95p...
  • News Source: Androscoggin News | about 1 month ago
    Macaque monkeys that received gene therapy for symptoms of Parkinson's disease saw a significant improvement in their motor function without the side effects associated with current standard therapy, researchers say. Simultaneous insertion of three...
  • News Source: The Courier-Mail | about 1 month ago
    Parkinson's disease that has been tested on lab monkeys is showing good early results in a small-scale trial on humans, French researchers say. The therapy entails taking three genes that produce dopamine, a vital neurochemical that is depleted in...
  • News Source: Xtra News | about 1 month ago
    Long-term tests on monkeys using Oxford BioMedica's gene therapy ProSavin suggest it can treat Parkinson's disease without causing the jerky, involuntary movements associated with current drugs, researchers said on Wednesday. Parkinson's is caused by...
Blogs
 >
  • Blog Source: berkeleylabreport.blogspot.com
    Gene therapy could remedy Parkinson's. But Palfi's team is the first to deliver all three of the dopamine genes in a single viral vector in primates. This approach aims to eliminate the need for L-DOPA and its associated side effects. ...
  • Blog Source: www.labspaces.net
    "Gene therapy is likely to be the best option -- if the problems encountered to date can be worked out," says Buckley. Gene therapy trials were halted in 2003 after some patients developed cancer following the therapy, but new trials ...
  • Blog Source: submitfreearticles.com
    Prostate cancer patients may use oral therapy, injection directly to the penis, drug suppositories, pellets or implants. The relationship of Parkinson Disease and Erectile dysfunction is more likely an imposed nervous system. ... Gene therapy.
  • Blog Source: www.stemcellstherapy.tv
    Gene Mutation May Speed Learning. Posted on October 14th, 2009 in Gene therapy. Finding might yield insights into diseases like Parkinson's, experts say Source: HealthDay. Related MedlinePlus Topics: Genes and Gene Therapy, Parkinson's ...
  • Blog Source: www.dentalplans.com
    The gene plays an important role in both the aging and proliferation of cells, and research is aimed at developing gene therapy not only for heart disease but also for some forms of cancer. The Japanese study used elderly mice that were ...
  • Blog Source: www.medical-medicine.us
    Gene therapy offers great potential for PD and many other brain disorders. With this type of therapy, viruses are engineered to deliver genes that increase the supply of dopamine, prevent cell death, or promote regeneration of neurons. Deep brain
Images
 >
 
Videos
 >
 
  • Posted By MohamedAliSaleh MohamedAliSaleh | about 1 month ago
    very niceee
    i used this report as a source for my seminar on genetic diseases
  • Report Your News Got a similar story?
    Add it to the network!

    Or add related content to this report

    Cell phones Cell phones use report code: @4391863

    Most Popular Reports

    Related Tweets

    Related Allvoices Reports

    Contributions

    Help and Accounts


    Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

    © Allvoices, Inc 2008-2009. All rights reserved.